Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
Other resources
Learn More
Other resources brands publish to help support patients.
people also ask
Recorlev FAQs
How is the dosage of Recorlev?Recorlev is available in 1 dosages, including 150 mg Tab
What does Recorlev treat?Recorlev treats Blastomycosis, Chronic Mucocutaneous Candidiasis, Cutaneous Candidiasis, Oral Candidiasis, Vulvovaginal Candidiasis, Coccidioidomycosis, Histoplasmosis, Leishmaniasis, Mycoses, Paracoccidioidomycosis, Seborrheic Dermatitis, Tinea Pedis, Tinea Versicolor and Acanthamoeba Keratitis
What is Recorlev made of?Recorlev contains ketoconazole which is a Azole Antifungal
How Is Recorlev Administered?Recorlev is administered as a Oral Pill
What Are The Recorlev Mechanism Of Action?Recorlev mechanism of action is Cytochrome P450 3A4 Inhibitors, Cytochrome P450 3A5 Inhibitors or P-Glycoprotein Inhibitors
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
